Apparent diffusion coefficient (ADC) has potential as a quantitative imaging biomarker for differentiation of malignant from benign tissue. Here, we present a phantom and in vivo measurement of ADC reproducibility and a restrospective study in over 100 patients with prostate cancer to evaluate ADC as a classifier.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: